Percutaneous coronary intervention as an alternative to bypass surgery for unprotected LMCA stenosis

Seung-Jung Park1, Young-Hak Kim

  • 1Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Seoul, Korea. sjpark@amc.seoul.kr

Insights

Percutaneous coronary intervention (PCI) with drug-eluting stents (DES) shows acceptable outcomes for unprotected left main coronary artery stenosis. Future studies are needed to compare PCI with CABG surgery for this condition.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Hemodynamically significant left main coronary artery (LMCA) stenosis affects ~4% of diagnostic coronary angiograms.
  • Unprotected LMCA stenosis occurs when bypass grafts to the left coronary artery and left circumflex artery are absent.
  • Coronary artery bypass graft (CABG) surgery has historically been recommended over medical treatment due to reduced mortality.

Purpose of the Study:

  • To evaluate the current clinical practice and outcomes of percutaneous coronary intervention (PCI) using drug-eluting stents (DES) for unprotected left main coronary artery (LMCA) stenosis.
  • To discuss the implications of recent advancements in DES technology on treatment guidelines for LMCA stenosis.
  • To highlight the need for future randomized trials comparing CABG and PCI for unprotected LMCA stenosis.

Main Methods:

  • Review of previous randomized studies comparing CABG with medical treatment for LMCA stenosis.
  • Analysis of reported long-term outcomes of PCI with DES for unprotected LMCA stenoses.
  • Discussion of current practice patterns and patient selection for PCI in cases of unprotected LMCA stenosis.

Main Results:

  • Previous studies demonstrated reduced mortality with CABG compared to medical treatment for LMCA stenosis.
  • Recent data suggest acceptable long-term outcomes for PCI using DES in treating unprotected LMCA stenoses.
  • PCI is increasingly utilized for high-risk or unwilling patients despite current guideline recommendations.

Conclusions:

  • Current guidelines favor CABG for unprotected LMCA stenosis due to proven benefits and historical concerns with bare metal stents.
  • The advent of DES has led to acceptable outcomes with PCI, prompting its use in specific patient populations.
  • Further randomized trials are essential to definitively compare CABG and PCI with DES for unprotected LMCA stenosis to inform clinical decision-making.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...